Global Pterygium Drug Market
Global Pterygium Drug Market

Global Pterygium Drug impressive market players are assessed on different parameters, for example, industry diagram, product portfolio, and income

The Global Pterygium Drug Market  research report is a perfect research manual which enables the client to comprehend the Global Pterygium Drug Market through its definition, segment study, market potential, upcoming patterns, and the difficulties that the market is confronting. The report has significant data about partners, key worldwide merchants, providers and contact data, top assembling gear providers and contact data, essential customers and contact data and production network relationship investigation. The impressive market players are assessed on different parameters, for example, industry diagram, product portfolio, and income. It displays an in-depth interpretation of overall Global Pterygium Drug Market.


Global pterygium drug market is rising gradually with a substantial CAGR in the forecast period of 2019-2026. Growing population of pterygium population worldwide and emergence of drugs used in the treatment of risk associated with pterygium disease are the key factors to drive the market growth.

The report additionally gives a portrayal of the competitive idea of the market, its shares, trends and a description of the leading business. Further, the report assesses changing business sector elements, development main impetuses, just as restrictions, and constraints in the market, which have been viewed as most powerful and could influence market development in a positive or negative way. The report additionally significantly breaks down the flawless business condition, which incorporates social, political, services, and financial worries and market section boundaries that may likewise influence the market’s development force

Global Pterygium Drug Market By Type (Progessive Pterygium and Atrophic Pterygium), Stage Type (Stage 0, Stage 1, Stage 2, Stage 3, Stage 4), Treatment Type (Medication and Surgery), Route of Administration (Oral, Injectable and Topical), End- Users (Hospitals, Homecare, Specialty Clinics, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026.

Key Market Players:

Few of the major competitors currently working in the global pterygium drug market are Novartis AG, Johnson & Johnson Services, Inc., Bausch Health, Sun Pharmaceutical Industries Ltd, ALLERGAN, Merck & Co., Inc, Pfizer Inc, XOMA, Allgenesis Biotherapeutics Inc, EyePoint Pharmaceuticals, Cloudbreak Therapeutics LLC, Enzo Biochem Inc., AbbVie Inc, TopiVert Ltd, Santen Pharmaceutical Co., Ltd., Regeneron Pharmaceuticals Inc, HanAll Biopharma, DAIICHI SANKYO COMPANY, LIMITED, Alphamab Co. Ltd, Coherus BioSciences, Ligand Pharmaceuticals Incorporated, Clearside Biomedical, Inc. and many others.

Market Definition: Global Pterygium Drug Market

Pterygium is also known as Surfer’s eye which is defined as an ocular degenerative condition of the non-cancerous growth of tissues on the surface of cornea of the eyes. It is characterized by the pinkish wing-shaped ocular surface lesion around the cornea. The patients with pterygium may experience dryness, grittiness, redness, pain and diminished vision. It is mostly affected in geriatric population.

According to the statistics published in the UpToDate, Inc, it is estimated that the total prevalence of pterygium varies from 1 to 25 percent of total worldwide population. This growing prevalence of pterygium worldwide and adoption of novel therapies for the treatment of pterygium are the key factors for contributing to the growth of this market..

Market Drivers

  1. Ongoing clinical trial studies being carried out by many pharmaceuticals industries acts as a driver for this market
  2. Exposure to certain toxin or change in environment may increase the pterygium disease which boosts the market growth
  3. Prevalence of indoor as well as outdoor allergens also enhances the market growth
  4. Increase in prevalence rate of pterygium disease worldwide plays an important role in the growth of this market

Market Restraints

  1. Effective treatment is either unavailable or unaffordable acts as a restraining factor for this market
  2. Patent expiry from many companies and introduction of generic drugs is expected to restrain the growth of the market.
  3. Inadequate knowledge about pterygium disease in some developing countries  is also hampering the market growth

Segmentation: Global Pterygium Drug Market

By Type

  • Progessive Pterygium
  • Atrophic Pterygium

By Stage Type

  • Stage 0: lesion is posterior to the limbus
  • Stage 1: lesion involves limbus
  • Stage 2: lesion appears just on the limbus
  • Stage 3: Lesion covers between the limbus and pupillary margin
  • Stage 4: lesion is central to the pupillary margin

By Treatment

  • Medication
    • Mitomycin C
    • Steroid Eye Drops
  • Surgery
    • Conjunctival Autograft
    • Amniotic Membrane Grafting

By Route of Administration

  • Oral
  • Injectable
  • Topical

 By End Users

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • South America
    • Brazil
    • Rest of South America
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Turkey
    • Belgium
    • Netherlands
    • Switzerland
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • South Korea
    • India
    • Australia
    • Singapore
    • Thailand
    • Malaysia
    • Indonesia
    • Philippines
    • Rest of Asia Pacific
  • Middle East & Africa
    • South Africa
    • Rest of Middle East & Africa

Key Developments in the Market:

In December 2018, Allgenesis Biotherapeutics Inc, received U.S. patent “multi-tyrosine kinase inhibitor in ophthalmic suspension for pterygium treatment” This U.S. grant of patent provides with coverage of Multi-Tyrosine Kinase Inhibitor in ophthalmic suspension and its used to treat pterygium up to 2036.

In September 2018, Cloudbreak Therapeutics LLC, is being developing CBT-001, a potent multi-kinase inhibitor of VEGFRs, PDGFRs, FGFRs for the treatment of pterygium. If clinical trial successful, it will significantly improve the treatment landscape of patients with pterygium by reducing the surgical intervention throughout the United States and worldwide.

Competitive Analysis:

Global pterygium drug market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares global pterygium drug market.

Research Methodology: Global Pterygium Drug Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report

  • Current and future global pterygium drug market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

About Data Bridge Market Research
An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.
Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475

About Data Bridge Market Research 11010 Articles
Hi, I am Ravi Kumar, a Blogger, Freelancer, SEO Consultant, an Internet Marketer, I am a research analyst who loves to evaluate data relating to Manufacturing industry, Management of companies and enterprises, Finance and insurance, Wholesale trade, Management, scientific, and technical consulting services

Leave a Reply

Your email address will not be published.